Piramal Pharma Solutions Supports Theracosbio With Integrated Drug Substance/drug Product Program For Bexagliflozin

TheracosBio recently received FDA approval for Brenzavvy (bexagliflozin), an oral sodium-glucose cotransporter 2 (SGLT2) inhibitorPiramal supported TheracosBio with starting materials, active

Related Keywords

Ennore ,Tamil Nadu ,India ,Mumbai ,Maharashtra ,United Kingdom ,Digwal ,Andhra Pradesh ,Morpeth ,Northumberland ,United States ,America ,Albertr Collinson ,Peter Deyoung ,Yapan Bio ,Exchange Board Of India ,Carlyle Group ,Drug Administration ,Piramal Pharma ,Contract Development ,Facebook ,Linkedin ,Yapan Bio Private ,Piramal Pharma Limited ,Piramal Pharma Solutions ,Manufacturing Organization ,Piramal Pharma Ltd ,Prnewswire Piramal Pharma Solutions ,Allergan ,Twitter ,Pharma Solutions ,Chief Executive Officer ,Piramal Global Pharma ,North America ,Pharma Limited ,Piramal Critical Care ,Complex Hospital Generics ,India Consumer Healthcare ,Exchange Board ,Piramal ,Dharma ,Solutions ,Supports ,Heracosbio ,Ith ,Ntegrated ,Drug ,Substance ,Product ,Program ,Exagliflozin ,